- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00120328 | Terminated | To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
2364 | All | 21 Years to 80 Years (Adult, Older Adult) | NCT00120328 | SPP301CRD15 2005-000604-14 |
July 2005 | February 2007 | July 15, 2005 | October 5, 2007 |
|